Author

Tomas Kucera

University Hospital Hradec Králové

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Anna MisiachnaiD· 2 shared Jakub FibigariD· 2 shared Jan KorábečnýiD· 2 shared Martin HořákiD· 2 shared Emily LangoreiD· 1 shared Eva MezeiováiD· 1 shared Jakub NetolickýiD· 1 shared Jiří JanoušekiD· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Anna MisiachnaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Morphing Cholinesterase Inhibitor Amiridine into Multipotent Drugs for the Treatment of Alzheimer's Disease

Eva Mezeiová, Lukáš Prchal, Martina Hrabinová, Ľubica Múčková, Lenka Pulkrabkova, Ondřej Soukup, Anna Misiachna, Jiří Janoušek, Jakub Fibigar, Tomas Kucera, Martin Hořák, Галина Ф. Махаева, Jan Korábečný

This study develops multi-target directed ligands (MTDLs) by modifying amiridine, a cholinesterase inhibitor, to enhance its therapeutic potential for Alzheimer's disease.

Biomedicine & Pharmacotherapy · Mar 15, 2024Peer-reviewedNeuroscience

Independent regulation of early trafficking of NMDA receptors by ligand-binding domains of the GluN1 and GluN2A subunits

Jakub Netolický, Petra Zahumenska, Anna Misiachna, Marharyta Kolcheva, Tomas Kucera, Jakub Fibigar, Kristyna Rehakova, Katarína Hemelíková, Štěpán Kortus, Emily Langore, Marek Ladislav, Jan Korábečný, Martin Hořák

This study shows that structural changes in the ligand-binding domains of GluN1 and GluN2A subunits independently regulate early trafficking of NMDARs and that surface expression does not always correlate with agonist sensitivity.

bioRxiv · Feb 2, 2024 · PreprintNeuroscience